NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study

CompletedNA

Sponsor: Massachusetts General Hospital

Conditions: HIV, Human Immunodeficiency Virus, ART

Interventions: HIV PrEP Delivery

Countries: South Africa

The overall goal is to determine whether an end-to-end decentralized delivery service for PrEP is more effective, safe, acceptable, and cost-effective than facility-based PrEP delivery.

Eligibility overview

Sex: ALL

Age: 16 Years to 30 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Aged 16 years - 30 years old,
* Self-report living without HIV or unknown status.
* Persons who have been sexually active within the last 3 months
* Interested in the use of PrEP for HIV prevention.
* Able and willing to provide informed consent for study procedures.
* Access to a cellphone for study related communication
* Reside in the study community for the duration of follow-up.

Exclusion Criteria:

* HIV infection based on negative HIV rapid tests
* Clinically ineligible for PrEP
* The participant doesn't reside in the study community for the duration of follow-up

Locations (1)

Durban, KwaZulu-Natal, South Africa